Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.
Complete responses (CR) in patients receiving atezolizumab (atezo) plus bevacizumab (bev) versus sorafenib (sor) in IMbrave150: A phase III clinical trial for unresectable hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020
van Beek, D. J.; Almquist, M.; Bergenfelz, A. O. et al.
COMPLICATIONS AFTER SURGERY FOR MEDULLARY THYROID CARCINOMA IN A LARGE EUROPEAN COHORTBRITISH JOURNAL OF SURGERY. Bd. 107. 2020 S. 10-11
Zahnreich, Sebastian; Weber, Britta; Roesch, Gundula et al.
Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2DNA REPAIR. Bd. 96. 2020
Westphalen, BC; Bokemeyer, C; Büttner, R et al.
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy, ArticleEUR J CANCER. Bd. Aug. H. 135. 2020 S. 1-7
Westphalen, Benedikt C.; Bokemeyer, Carsten; Buettner, Reinhard et al.
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'EUROPEAN JOURNAL OF CANCER. Bd. 135. 2020 S. 1-7
Briggs, Andrew; Daniele, Bruno; Dick, Katherine et al.
Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinomaBRITISH JOURNAL OF CANCER. 2020
Sprang, Maximilian; Paret, Claudia; Faber, Joerg
CpG-Islands as Markers for Liquid Biopsies of Cancer PatientsCELLS. Bd. 9. H. 8. 2020
Theobald, M
Current immunotherapeutic strategies in cancerSpringer 2020 1 S.
Pielenhofer, Jonas; Sohl, Julian; Windbergs, Maike et al.
Current Progress in Particle-Based Systems for Transdermal Vaccine DeliveryFRONTIERS IN IMMUNOLOGY. Bd. 11. 2020
Kaina, Bernd; Beltzig, Lea; Piee-Staffa, Andrea et al.
Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma CellsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 21. H. 19. 2020